Showing results (311-320 of 3,351) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|April 12, 2021
Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupDaniel C Bowers, Lisanne C Verbruggen, Leontien C M Kremer, et al.
The Lancet. Oncology|April 16, 2021
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trialThierry Conroy, Jean-François Bosset, Pierre-Luc Etienne, et al.
The Lancet. Oncology|April 23, 2021
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancerMaria Alice Franzoi, Elisa Agostinetto, Marta Perachino, et al.
The Lancet. Oncology|September 10, 2002
Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent diseaseMark Harries, Martin Gore
The Lancet. Oncology|September 10, 2002
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of careTejpal Gupta, Rajiv Sarin
The Lancet. Oncology|July 31, 2002
Kenya faces cancer challengeClare Sansom, Geoffrey Mutuma
The Lancet. Oncology|July 31, 2002
Hyperthermia in combined treatment of cancerP Wust, B Hildebrandt, G Sreenivasa, et al.
The Lancet. Oncology|January 9, 2003
Childhood nasopharyngeal carcinoma: from biology to treatmentInci Ayan, Esra Kaytan, Nihat Ayan
The Lancet. Oncology|January 9, 2003
Lung cancer in Europe in 2000: epidemiology, prevention, and early detectionJerzy E Tyczynski, Freddie Bray, D Maxwell Parkin
The Lancet. Oncology|February 8, 2003
Splenic marginal-zone lymphoma: a distinct clinical and pathological entityCatherine Thieblemont, Pascale Felman, Evelyne Callet-Bauchu, et al.
Pageof 336